Scott Smith is the founder of BioAtla. BioAtla has raised $73M in total funding. Latest round: Series D. Based in San Diego, United States.
Scott Smith is the President of BioAtla, a global clinical-stage biotechnology company. BioAtla focuses on developing Conditionally Active Biologic (CAB) antibody therapeutics designed to have more selective targeting and greater efficacy. The company raised $72.5 million in a Series D financing round in July 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library